The Intrinsically Disordered Region of HBx and Virus–Host Interactions: Uncovering New Therapeutic Approaches for HBV and Cancer
International Journal of Molecular Sciences · 10.04.2025 · 26 (8) · 3552
DOI: 10.3390/ijms26083552 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.04.2025. Verfasst von Rodrigo A Villanueva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centro Científico y Tecnológico de Excelencia Ciencia & Vida, Fundación Ciencia & Vida, Santiago 8580702, Chile. Hauptthemen laut MEDLINE: Hepatitis B virus, Trans-Activators, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, Agencia Nacional de Investigación y Desarrollo, National Agency of Research and Development (ANID): “Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia Centro Ciencia & Vida”.
Abstract (Originalsprache)
Human viral infections remain a significant global health challenge, contributing to a substantial number of cancer cases worldwide. Among them, infections with oncoviruses such as hepatitis B virus (HBV) and hepatitis C virus (HCV) are key drivers of hepatocellular carcinoma (HCC). Despite the availability of an effective HBV vaccine since the 1980s, millions remain chronically infected due to the persistence of covalently closed circular DNA (cccDNA) as a reservoir in hepatocytes. Current antiviral therapies, including nucleos(t)ide analogs and interferon, effectively suppress viral replication but fail to eliminate cccDNA, underscoring the urgent need for innovative therapeutic strategies. Direct-acting antiviral agents (DAAs), which have revolutionized HCV treatment with high cure rates, offer a promising model for HBV therapy. A particularly attractive target is the intrinsically disordered region (IDR) of the HBx protein, which regulates cccDNA transcription, viral replication, and oncogenesis by interacting with key host proteins. DAAs targeting these interactions could inhibit viral persistence, suppress oncogenic signaling, and overcome treatment resistance. This review highlights the potential of HBx-directed DAAs to complement existing therapies, offering renewed hope for a functional HBV cure and reduced cancer risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Científico y Tecnológico de Excelencia Ciencia & Vida, Fundación Ciencia & Vida, Santiago 8580702, Chile.
- Facultad de Ciencias, Universidad San Sebastián, Santiago 7510602, Chile.
ORCID-Profile: Alejandra Loyola
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Agencia Nacional de Investigación y Desarrollo
- National Agency of Research and Development (ANID): “Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia Centro Ciencia & Vida”
Zitieren
APA
Villanueva, R. A., & Loyola, A. (2025). The Intrinsically Disordered Region of HBx and Virus–Host Interactions: Uncovering New Therapeutic Approaches for HBV and Cancer. International Journal of Molecular Sciences, 26(8), 3552. https://doi.org/10.3390/ijms26083552
Vancouver
Villanueva RA, Loyola A. The Intrinsically Disordered Region of HBx and Virus–Host Interactions: Uncovering New Therapeutic Approaches for HBV and Cancer. International Journal of Molecular Sciences. 2025;26(8):3552. doi:10.3390/ijms26083552
BibTeX
@article{Villanueva2025,
author = {Villanueva, Rodrigo A and Loyola, Alejandra},
title = {The Intrinsically Disordered Region of HBx and Virus–Host Interactions: Uncovering New Therapeutic Approaches for HBV and Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3552},
doi = {10.3390/ijms26083552}
}
EUVIMED